Single-institution experience with 18F-DOPA and 68Ga-DOTA-TOC as a PET imaging tracer for peptide receptor radionuclide therapy in well-differentiated neuroendocrine neoplasms

被引：0

|

作者：

Veenstra, E. ^{[1
]}

Noordzij, W. ^{[1
]}

机构：

[1] Univ Med Ctr Groningen, Groningen, Netherlands

来源：

JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷

关键词：

neuroendocrine tumor; pet tracer; 18f-dopa; 68ga-dota-toc; carbidopa; peptide receptor radionuclide therapy; prrt;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

K32

引用

收藏

页码：199 / 199

页数：1

相关论文

共 32 条

[31] Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging
Zhang, Jingjing
Kulkarni, Harshad R.
Baum, Richard P.
CLINICAL NUCLEAR MEDICINE, 2020, 45 (02) : E125 - E127
[32] Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography (68Ga-DOTATATE and18F-fluorodeoxyglucose) molecular imaging and disease stabilization following177Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy
Jadhav, Sonali
Basu, Sandip
WORLD JOURNAL OF NUCLEAR MEDICINE, 2019, 18 (04) : 431 - 433

← 1 2 3 4 →